Short answer
The first case is evidence, not a milestone to archive. Use it to update patient selection, training, supply, workflow, the evidence plan, and the order of later sites before the same assumption is copied across the launch.
The Intuitive Surgical case
Intuitive Surgical received FDA clearance for the da Vinci Surgical System for general laparoscopic procedures in July 2000. Its 2001 annual report described a sales strategy focused on large multispecialty hospitals where many complex procedures were performed.
That was a reasonable starting point for a new surgical platform. It did not settle which procedure would carry the commercial model.
In May 2001, Intuitive received clearance to promote the system for laparoscopic radical prostatectomy. By its 2003 annual report, the company said the mix of da Vinci procedures across its three main specialties was largest in urology, followed by cardiothoracic and general surgery. It had also changed the description of its institutional focus from large multispecialty hospitals to both academic and community hospitals.
The move became clearer in 2004. Intuitive reported that use of da Vinci for radical prostatectomy grew more than 200% from 2003 to 2004 and contributed significantly to sales growth. At the end of 2004, it had sold 286 systems, compared with 210 a year earlier. Full-year sales reached $138.8 million, up from $91.7 million. Recurring revenue from instruments, accessories, service, and training reached $60 million, compared with $29.9 million in 2003. The company said the recurring growth came from a larger installed base and increased system use.
By the end of 2005, Intuitive had sold 401 systems and said surgeons had completed tens of thousands of procedures. Urology remained the largest of the four main specialty groups it then reported. The company estimated that more than 20% of U.S. radical prostatectomies in the fourth quarter of 2005 used da Vinci.
The public filings do not identify the first prostatectomy case that changed the company's plan. They do show the larger sequence: a broadly cleared surgical platform, additional procedure-specific clearances, an early focus on major institutions, a procedure mix that became largest in urology, rapid growth in prostatectomy use, and a wider focus that included community hospitals.
This is what early cases can do. They do not only test whether the product works. They show which part of the launch model deserves to be repeated.
A completed case is seven observations
Launch teams often record a first case as one event: completed, successful, announced.
Commercially, a first case is at least seven observations.
Patient selection: Was this the patient profile the plan expected, and how many people were screened to find one?
Training: Which steps could the site perform from training, and where did it still need support?
Supply: What was opened, wasted, missing, substituted, or reordered?
Workflow: How long did preparation, procedure, turnover, and follow-up take, and which department absorbed the extra work?
Economics: Did billing, reimbursement, staffing, room time, or product use change the site's view of the case?
Evidence: Which data were captured, and which question became more important after use?
Site sequence: Did the case support the next planned site, or show that a different site should open first?
A clinical result can be accepted while the site's unresolved question moves to staffing, payment, or room economics. A launch review should update all seven while the details are current.
The point is not to overreact to one patient. The point is to prevent the launch plan from remaining unchanged when its first direct evidence arrives.
Update patient selection before volume
A first case may be clinically successful and still expose weak patient selection.
The patient may have been easier than the planned commercial population. The physician may have screened ten patients to find one. An imaging requirement may remove half the expected pool. A referring clinician may interpret the indication more narrowly than the launch team did. A payer may require documentation that the site does not routinely collect.
These observations should update the patient funnel, not just the case report.
Record:
- patients considered;
- patients meeting the label and site criteria;
- exclusions and their reasons;
- patients who reached authorization;
- patients scheduled; and
- time between each step.
The revised funnel should then reopen the volume assumption. If the plan expected one case from every three screened patients and the first sites require eight, inventory, clinical support, revenue timing, and site targets may all change.
The Intuitive record shows why the procedure matters. A broad platform can support many clinical applications, but commercial use concentrates where the patient, physician, workflow, and benefit align well enough to repeat. The early plan should be able to follow that evidence.
Change training from a curriculum to a readiness gate
Training completion is an activity. Readiness is an operating judgment.
After the first case, separate what the team knew from what the launch team carried for them.
A useful case review records support by step:
| Step | Site performed independently | Launch support required | Change before next case |
|---|---|---|---|
| Patient confirmation | Yes or no | Clinical, reimbursement, none | Criteria or documentation update |
| Room preparation | Yes or no | Specialist, checklist, equipment | Setup sequence update |
| Procedure | Yes or no | Proctor, specialist, technical | Training or case-selection update |
| Close and turnover | Yes or no | Supply or nursing | Kit or workflow update |
| Follow-up | Yes or no | Clinical or data team | Owner and schedule update |
The next case should not use the same support by default. It should test whether the change worked.
Intuitive's 2005 filing reported that customer training revenue rose to $1.1 million from $0.9 million in 2004, mainly because of higher system unit sales. That number is small beside system revenue, but the filing places training inside the recurring operating model. More placements produced more training demand.
Training capacity therefore belongs in the site-opening decision. A launch cannot open ten sites in a month if its people can only make three ready.
Let use change the supply plan
The first case is the first real bill of materials under commercial conditions.
Forecasts usually assume a standard kit, expected waste, and a reorder point. The first case may show that the site opens backup items early, uses a different size mix, needs another accessory, or consumes product during setup and training.
Update four records:
- what the case was expected to consume;
- what it actually consumed;
- what must be available for the next case; and
- who owns the reorder.
Then check whether the change applies to one site or the launch.
The supply response should remain a decision. One unusual case does not justify rebuilding every kit. It does justify checking the assumption before the same kit is shipped to four more sites.
Map the real workflow, including waiting
Procedure time gets attention because it is visible. Waiting often carries more commercial cost.
The first case can expose days between referral and consult, weeks for authorization, a delayed room block, missing credentialing, a handoff to another department, or a follow-up visit that nobody scheduled.
Draw the case from patient identification through the first follow-up. Add the owner and elapsed time at every handoff.
For an implantable therapy, the procedure may be one part of a longer path. Inspire's published commercial process, for example, included diagnosis, authorization, implant, activation about a month later, and later sleep-study follow-up. A launch team looking only at the implant would miss much of the system that produces the outcome and the next referral.
The first case should replace the slide version of the workflow with the observed one.
Change the evidence plan when the question changes
The first cases rarely answer the whole evidence question. They often change it.
A company may enter launch expecting to prove procedure time. The first sites may accept the time but ask about staffing. The clinical result may be clear while the economic objection moves to length of stay, readmissions, capital use, or follow-up burden. A physician may ask for a subgroup the original evidence plan did not separate.
Record three things after each early case:
- evidence the case added;
- evidence the account requested; and
- evidence the company still cannot provide.
Then decide whether the missing item changes the next site.
The next site should be chosen partly for the evidence gap created by the last case.
Reorder the launch before scaling the mistake
The original site sequence is based on pre-launch evidence: champion interest, contracting, volume, geography, prestige, and expected timing.
The first case adds operating evidence. It should be allowed to change the order.
Use a simple review:
| Observation from early case | Decision to reopen |
|---|---|
| Eligible patients are narrower than expected | Later-site volume threshold and patient mix |
| Site needs more proctor or specialist support | Training capacity and opening cadence |
| Setup requires another department | Site-readiness gate and contracting owner |
| Product mix differs from forecast | Starter inventory and reorder point |
| Economic question changes | Evidence site and value packet |
| Second case is not scheduled | Referral pathway and repeat-use test |
Review the case twice
Hold the first review within one working day, while the workarounds are still visible. Include the account lead, clinical support, training, supply, reimbursement, and evidence owner. Ask:
- What differed from the plan?
- Which difference belonged to this patient or this site?
- Which assumption is now weaker or stronger?
- What changes before the next case?
- Which later-site decision needs review?
- Who approves the change, and by when?
Then review the site again after 30 days. The second review asks a different question: did the first case create a working path to another one?
Check whether another eligible patient was found, whether authorization moved, whether the trained team retained readiness, whether inventory was reordered, whether follow-up happened, whether the site asked a new economic or evidence question, and whether a second case was scheduled.
The first review captures how the launch met the workflow. The second captures whether the site can repeat without the launch team recreating the first case by hand.
What this does not prove
Intuitive's filings do not show that one early prostatectomy case caused a change in company strategy. They do not disclose an internal first-case review, and the revenue figures do not prove that prostatectomy growth alone produced the company's overall growth.
They do show a change in the observed commercial pattern. The company moved from a broad laparoscopic platform and an early focus on large multispecialty hospitals to a procedure mix led by urology, a focus that included community hospitals, and prostatectomy use growing more than 200% in 2004. Recurring revenue also rose as the installed base and system use increased.
The lesson is not that every platform should find one dominant procedure. It is that the launch plan should change when real use shows where repeatability is forming.
The first case is the first version of the launch that actually happened. Update the plan before opening the next site.
Sources
- Intuitive Surgical, 2001 Form 10-K: sec.gov
- Intuitive Surgical, 2003 Form 10-K, filed March 9, 2004: sec.gov
- Intuitive Surgical, 2004 Form 10-K, filed March 16, 2005: sec.gov
- Intuitive Surgical, "Record $45.2 Million Fourth Quarter Revenue," February 8, 2005: sec.gov
- Intuitive Surgical, 2005 Form 10-K, filed March 14, 2006: sec.gov
- U.S. Food and Drug Administration, 510(k) K011002: accessdata.fda.gov
Frequently asked questions
- What should a launch team record after a first case?
- Six observations, not one event: patient selection (how many screened to find one), training (what the team could do alone versus with launch support), supply (what was opened, wasted, missing, or substituted), workflow (real elapsed time including waiting), evidence (what was captured and what the account asked for), and site sequence (whether the next planned site should still come next).
- Why update patient selection before chasing volume?
- A clinically successful first case can still expose weak selection — the patient may have been easier than the planned commercial population, or the physician screened ten patients to find one. The revised funnel reopens the volume assumption: if the plan expected one case from three screened patients and sites require eight, inventory, support, revenue timing, and site targets all change.
- What is the difference between training completion and readiness?
- Completion is an activity; readiness is an operating judgment. A case review should record, step by step, what the site performed independently and where it needed launch support — then change the criteria, checklist, or training before the next case. Training capacity also belongs in the site-opening decision: a launch cannot open ten sites in a month if its people can only make three ready.
- What is a 48-hour case review?
- A review held within two working days of an early case, including the account lead, clinical support, training, supply, reimbursement, and the evidence owner. It asks six questions: what differed from the plan, which difference was site-specific, which assumption is weaker or stronger, what changes before the next case, which later-site decision needs review, and who approves the change by when.
- Should one unusual case change the whole launch plan?
- Not by itself. The supply or workflow response should remain a decision — one unusual case does not justify rebuilding every kit. It does justify checking the assumption before the same kit, schedule, or site profile is shipped to four more sites.